FDA approves diabetes drug with evidence of superior blood sugar control
By
Alicia Lasek (f3)
May 17, 2022
Mounjaro was more effective than other type 2 diabetes drugs at helping clinical trial participants control blood sugar and lose weight, the FDA reports.
Contested insulin therapy remains common in nursing homes: study
By
Alicia Lasek
Apr 01, 2022
Despite being discouraged in the elderly, a facilities study has found that sliding scale insulin therapy is used in 21% of newly admitted residents who receive the drug for type 2 diabetes and is continued...
Clinical briefs for Monday, Nov. 1
By
Alicia Lasek
Nov 01, 2021
Decreased vaccine efficacy tied to uptick in COVID cases, Israeli study finds … Newer glucose reducing drugs not linked to fracture risk in seniors with type 2 diabetes: study … Pitfalls of telehealth...
Poorly controlled diabetes — not diabetes itself — triples dementia risk, study finds
By
Alicia Lasek
Oct 13, 2021
In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
CDC data reveal drug types most linked to emergency department visits among seniors
By
Alicia Lasek
Oct 06, 2021
Emergency department visits for medication harm to older adults most frequently involve prescribed anticoagulants and diabetes drugs, according to a new federal study.
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Clinical briefs for Monday, July 12
By
Alicia Lasek
Jul 12, 2021
Judge rejects claim that Zostavax caused man’s shingles eight years later … Get blood sugar under control early in type 2 diabetes to cut odds of these poor outcomes: experts … Arthritis drug reduces...
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Among short-lived diabetes treatments, a combo therapy lasts
By
Alicia Lasek
Nov 04, 2020
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical...
Diabetes overtreated in older adults at end of life, study finds
By
Alicia Lasek
Jun 25, 2020
Diabetes appears to be overtreated in nearly 44% of recently admitted VA nursing home residents, including those with limited life expectancy and/or advanced dementia.